Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Feb 2022
Historique:
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 16 2 2022
Statut: ppublish

Résumé

BackgroundThe COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases.AimWe explored the possibility to use Cq values from SARS-CoV-2 screening tests to better understand the spread of an epidemic and to better understand the biology of the infection.MethodsWe used linear regression models to analyse a large database of 793,479 Cq values from tests performed on more than 2 million samples between 21 January and 30 November 2020, i.e. the first two pandemic waves. We performed time series analysis using autoregressive integrated moving average (ARIMA) models to estimate whether Cq data information improves short-term predictions of epidemiological dynamics.ResultsAlthough we found that the Cq values varied depending on the testing laboratory or the assay used, we detected strong significant trends associated with patient age, number of days after symptoms onset or the state of the epidemic (the temporal reproduction number) at the time of the test. Furthermore, knowing the quartiles of the Cq distribution greatly reduced the error in predicting the temporal reproduction number of the COVID-19 epidemic.ConclusionOur results suggest that Cq values of screening tests performed in the general population generate testable hypotheses and help improve short-term predictions for epidemic surveillance.

Identifiants

pubmed: 35144725
doi: 10.2807/1560-7917.ES.2022.27.6.2100406
pmc: PMC8832522
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2021 Jul;26(28):
pubmed: 34269174
Euro Surveill. 2021 Sep;26(37):
pubmed: 34533119
Nature. 2021 Feb;590(7844):134-139
pubmed: 33348340
Epidemics. 2019 Dec;29:100356
pubmed: 31624039
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Elife. 2021 Jul 12;10:
pubmed: 34250907
Epidemics. 2021 Jun;35:100459
pubmed: 34015676
Int J Infect Dis. 2021 Dec;113:12-14
pubmed: 34601145
Trends Microbiol. 2021 Nov;29(11):970-972
pubmed: 34535373
J Gen Virol. 2020 Sep;101(9):925-940
pubmed: 32568027
Int J Epidemiol. 2022 Jan 6;50(6):1795-1803
pubmed: 34999848
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662
pubmed: 32868447
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Nature. 2021 Jan;589(7840):125-130
pubmed: 32906143
Aging Dis. 2020 Dec 1;11(6):1481-1495
pubmed: 33269102
Emerg Infect Dis. 2021 May;27(5):1496-1499
pubmed: 33769253
Science. 2021 Jul 16;373(6552):
pubmed: 34083451
MMWR Morb Mortal Wkly Rep. 2021 Aug 06;70(31):1059-1062
pubmed: 34351882
Int J Infect Dis. 2021 Oct;111:100-107
pubmed: 34403783
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33536313
Science. 2021 Aug 20;373(6557):889-895
pubmed: 34301854
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Sci Data. 2020 Oct 8;7(1):345
pubmed: 33033256

Auteurs

Samuel Alizon (S)

MIVEGEC, CNRS, IRD, Université de Montpellier, France.
Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.

Christian Selinger (C)

MIVEGEC, CNRS, IRD, Université de Montpellier, France.

Mircea T Sofonea (MT)

MIVEGEC, CNRS, IRD, Université de Montpellier, France.

Stéphanie Haim-Boukobza (S)

Laboratoire CERBA, Saint-Ouen-L'Aumône, France.

Jean-Marc Giannoli (JM)

BIOGROUP, Scientific Direction, Lyon, France.

Laetitia Ninove (L)

Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.

Sylvie Pillet (S)

Laboratoire des agents infectieux et d'hygiène, CHU de Saint-Etienne, France.
CIRI, Centre International de Recherche en Infectiologie, GIMAP team, University of Lyon, University of Saint-Etienne, INSERM, U1111, CNRS UMR5308, ENS de Lyon, UCBL, Lyon, France.

Vincent Thibault (V)

Laboratoire de Virologie, CHU Rennes, Rennes, France.

Alexis de Rougemont (A)

UMR PAM A 02.102 Procédés Alimentaires et Microbiologiques, Université de Bourgogne Franche-Comté/AgroSup Dijon, Dijon, France.
Laboratory of Virology-Serology, University Hospital of Dijon Bourgogne, Dijon, France.

Camille Tumiotto (C)

University of Bordeaux, CNRS-UMR 5234, CHU Bordeaux, Virology Department, Bordeaux, France.

Morgane Solis (M)

CHU de Strasbourg, Laboratoire de Virologie, Strasbourg, France, Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France.

Robin Stephan (R)

Laboratoire de Microbiologie, CHU Nîmes, Nîmes, France.

Céline Bressollette-Bodin (C)

CHU Nantes, Nantes Université, Service de Virologie, Nantes, France.

Maud Salmona (M)

Laboratoire de Virologie, Hôpital Saint Louis, APHP, INSERM U976, équipe INSIGHT, Université de Paris, Paris, France.

Anne-Sophie L'Honneur (AS)

Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Virologie, Paris, France.

Sylvie Behillil (S)

National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, UMR 3569 CNRS, University of Paris, Institut Pasteur, Paris, France.

Caroline Lefeuvre (C)

Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU d'Angers, Angers, France.
Laboratoire HIFIH, UPRES EA 3859, Université d'Angers, Angers, France.

Julia Dina (J)

Laboratoire de Virologie, CHU de Caen, UNICAEN, INSERM U1311 DYNAMICURE, Université de Caen Normandie, Caen, France.

Sébastien Hantz (S)

CHU Limoges, Laboratoire de Bactériologie-Virologie-Hygiène, Limoges, France.
RESINFIT, U 1092, University of Limoges, Limoges, France.

Cédric Hartard (C)

Laboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-lès-Nancy, France; Université de Lorraine, CNRS, LCPME, Nancy, France.

David Veyer (D)

Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris et Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France.

Héloïse M Delagrèverie (HM)

AP-HP, Hôpital Avicenne, Laboratoire de microbiologie clinique, Bobigny, France.

Slim Fourati (S)

Henri Mondor Hospital, virology department, Créteil, France.

Benoît Visseaux (B)

Université de Paris, Inserm, UMR 1137 IAME et Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.

Cécile Henquell (C)

Service de Virologie médicale, 3IHP, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Bruno Lina (B)

CNR des virus des infections respiratoires (dont la Grippe), Institut des Agents Infectieux, Hopital de la Croix Rousse, HCL, Lyon, France.

Vincent Foulongne (V)

Pathogenesis and control of chronic and emerging infections, Université de Montpellier, UMR 1058, CHU de Montpellier, Inserm, Université des Antilles, Montpellier, France.

Sonia Burrel (S)

Sorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
French Society of Microbiology (SFM), https://www.sfm-microbiologie.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH